Telos Capital Management Inc. Acquires Shares of 2,386 Eastman Chemical (NYSE:EMN)

Telos Capital Management Inc. acquired a new stake in Eastman Chemical (NYSE:EMNFree Report) during the fourth quarter, HoldingsChannel reports. The fund acquired 2,386 shares of the basic materials company’s stock, valued at approximately $214,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Turtle Creek Wealth Advisors LLC bought a new position in Eastman Chemical in the fourth quarter valued at approximately $26,000. First Command Advisory Services Inc. bought a new position in Eastman Chemical in the third quarter valued at approximately $26,000. Cornerstone Planning Group LLC bought a new position in Eastman Chemical in the second quarter valued at approximately $33,000. Sound Income Strategies LLC boosted its stake in Eastman Chemical by 213.8% in the fourth quarter. Sound Income Strategies LLC now owns 408 shares of the basic materials company’s stock valued at $37,000 after acquiring an additional 278 shares during the last quarter. Finally, Bruce G. Allen Investments LLC acquired a new stake in Eastman Chemical in the fourth quarter worth $38,000. 83.65% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Eastman Chemical news, SVP Adrian James Holt sold 4,735 shares of Eastman Chemical stock in a transaction dated Wednesday, March 6th. The shares were sold at an average price of $87.75, for a total value of $415,496.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.93% of the company’s stock.

Eastman Chemical Stock Performance

Shares of EMN stock opened at $95.97 on Thursday. The company has a market capitalization of $11.29 billion, a price-to-earnings ratio of 12.81, a PEG ratio of 1.07 and a beta of 1.54. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.70 and a current ratio of 1.35. The company has a 50-day simple moving average of $92.17 and a 200 day simple moving average of $85.40. Eastman Chemical has a 52 week low of $68.89 and a 52 week high of $102.71.

Eastman Chemical (NYSE:EMNGet Free Report) last announced its earnings results on Friday, February 2nd. The basic materials company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.28 by $0.03. Eastman Chemical had a net margin of 9.71% and a return on equity of 14.15%. The business had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.21 billion. During the same quarter in the previous year, the firm posted $0.89 EPS. Eastman Chemical’s revenue was down 7.0% compared to the same quarter last year. On average, sell-side analysts predict that Eastman Chemical will post 7.7 earnings per share for the current year.

Eastman Chemical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Friday, March 15th were paid a $0.81 dividend. This represents a $3.24 annualized dividend and a yield of 3.38%. The ex-dividend date was Thursday, March 14th. Eastman Chemical’s dividend payout ratio (DPR) is 43.26%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Wells Fargo & Company increased their target price on shares of Eastman Chemical from $89.00 to $100.00 and gave the stock an “equal weight” rating in a report on Thursday, April 11th. KeyCorp increased their target price on shares of Eastman Chemical from $101.00 to $121.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Citigroup increased their target price on shares of Eastman Chemical from $95.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Redburn Atlantic started coverage on shares of Eastman Chemical in a report on Thursday, February 15th. They set a “buy” rating and a $110.00 price objective on the stock. Finally, Royal Bank of Canada decreased their target price on shares of Eastman Chemical from $91.00 to $89.00 and set a “sector perform” rating for the company in a research report on Tuesday, February 6th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Eastman Chemical currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.13.

Read Our Latest Research Report on EMN

Eastman Chemical Profile

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

See Also

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.